MalnutritionEZAFFAWNCT06092515
Efficacy of Zinc Fortified Fermented Wheat Flour
A study testing Fermented High Zinc Wheat Flour Flatbread, Unfermented High Zinc Wheat Flour Flatbread and Post-Harvest Fortified Whole Wheat Flour Flatbread in people with Malnutrition and Diabetes, run by Aga Khan University at 1 site in Pakistan.
Trial summary
Zinc is a pivotal micronutrient that participates in numerous essential metabolic pathways within the human body. Its multifaceted role makes the manifestations of zinc deficiency remarkably nonspecific and age-dependent. Read more about this study
- Who is it for?
- Ages 10 to 40 yearsHealthy volunteers can take part
- Conditions the study is for
- Malnutrition, Diabetes, Inflammation
- What is being tested?
- Fermented High Zinc Wheat Flour Flatbread, Unfermented High Zinc Wheat Flour Flatbread and Post-Harvest Fortified Whole Wheat Flour Flatbread
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,044 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Jan 2023to 31 May 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 10 to 40 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- Adolescents aged 10-19 years
- Adult women aged 20-40 years.
- Wheat as a staple part of their diet
Who cannot join
- Severe Malnutrition
- Pregnant or Lactating
- Chronic Diseases
- Participation in Similar Programs
- Individuals taking vitamin or mineral supplements at the time of enrollment
- Planned Relocation from the study area within the next 6-7
Trial locations and contacts
1 site in 1 country.
About this study
Official title: EZAFFAW - Efficacy of Zinc Fortified Fermented Wheat Flour: Randomized Controlled Trial
Zinc is a pivotal micronutrient that participates in numerous essential metabolic pathways within the human body. Its multifaceted role makes the manifestations of zinc deficiency remarkably nonspecific and age-dependent. In children, zinc deficiency can manifest as growth retardation, cognitive impairment, recurrent infections, and other diverse symptoms. Adolescents and adults may experience fertility issues, work capacity impairment, and metabolic disorders due to zinc deficiency. Furthermore, zinc plays a crucial role in maintaining immune function, particularly in the elderly, where recurrent infections can be a notable outcome of deficiency. Given its fundamental importance, the potential benefits of zinc supplementation and fortification strategies have been explored, with some evidence indicating positive effects on health outcomes such as childhood mortality, diarrhea morbidity, and even risk factors for conditions like Type 2 Diabetes (T2DM) and cardiovascular disease (CVD). Understanding zinc's significance in these metabolic processes is vital for addressing deficiencies and improving public health.
A study is needed to assess the effect of various types of fermented and unfermented wheat flour flatbread and its impact on health including zinc status, anthropometric outcomes, risk of T2DM and CVD and morbidity on adolescent and adult females. The whole wheat flatbread trial would be ideal to inform policy as it is regularly consumed in Sindh as most people rely on chakki for wheat grinding and it is used commonly to make roti at home.
Read the detailed description
STUDY DESIGN
This will be an individually randomized, double-blind efficacy trial in Mithi, District Tharparkar, Sindh, Pakistan. This district is among the most impoverished in Sindh, characterized by a tropical desert climate with extremely hot mornings. Approximately 87% of the population in Tharparkar lives below the poverty line. Due to its challenging demographics and environmental conditions, the region has endured severe droughts and faces the highest level of food insecurity among Sindh districts. It is concerning that 60% of children under five years suffer from stunting, 33.3% from wasting, and nearly 19.8% experience both conditions simultaneously. Additionally, approximately 40.4% of non-pregnant women of reproductive age are underweight. Tharparkar has been selected for this study due to its alarming rates of malnutrition and micronutrient deficiencies, making it an ideal location to assess the effectiveness of fortified wheat flour.
RESEARCH QUESTION
- Primary Does consumption of whole wheat flatbread made with fermented and unfermented 'high zinc wheat' or with 'post-harvest zinc-fortified wheat flour' improve zinc status and metabolic health among adolescents (10-19 years) and adult women (20-40 years) at high risk of zinc deficiency and T2DM compared to 'low zinc' whole wheat flatbread?
- Secondary Does an increase in bioavailable dietary zinc intake improve indicators for predicting the risk of T2DM in adolescents and adult women at high risk of zinc deficiency? SPECIFIC OBJECTIVES
- Primary To evaluate the efficacy of whole wheat flatbread made with fermented and unfermented 'high zinc wheat' or post-harvest zinc-fortified wheat on zinc status/zinc deficiency and metabolic health among adolescents and adult women at high risk of zinc deficiency when compared to the 'low zinc' whole wheat flatbread.
- Secondary To assess if an increase in bioavailable dietary zinc intake improves indicators for predicting the risk of T2DM in adolescents and adult women at high risk of zinc deficiency.
PARTICIPANTS The study will include adolescents (10-19 years) and adult women (20-40 years) INTERVENTION
Participants will be randomly divided into four groups according to the four-arm design in a 1:1:1:1 ratio. A total of 1000 participants would be randomly allocated to each of the groups in a 1:1:1:1 ratio.
- Group 1: will receive fermented high zinc wheat flour flatbread
- Group 2: will receive unfermented high zinc wheat flour flatbread
- Group 3: will receive fortified (post-harvest) whole wheat flour flatbread
- Group 4: will receive low zinc whole wheat flour flatbread
It would be a six-month intervention, where the participants would be given flatbread with a vegetable/pulse (daal) each day for six days a week for six months. On average, 2-3 flatbreads will be provided per participant (this was ascertained in the pilot activity). This would be provided at the school/college campus at lunch time i.e., at 1.30pm and all the participants enrolled in the study would be directly observed each day for the amount consumed and adult women would be provided meal at a community place.
OUTCOMES
Primary:
- Serum zinc concentration
- Zinc deficiency
- HbA1C
- Fasting blood glucose
- Insulin levels
- HOMA-IR (cut-off >2) (27)
- Lipid profile (total cholesterol, very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), high-density lipoprotein (HDL); triglycerides (TGs))
- Red blood cell membrane fatty acids concentrations
Secondary:
- Anthropometric measurements:
- Height
- Weight
- Mid upper arm circumference (MUAC)
- Waist circumference
- Body Mass Index (BMI) - Severe thinness, thinness, normal weight, overweight, obese
- Blood Pressure
- Anemia
- School attendance/ performance
- Dietary intakes through 24hr dietary recall.
- Morbidity - Diarrhea, Acute respiratory infection (ARI) etc.
Compliance:
- Number of days each participant had flatbread
- Flatbread consumed (weight) each day
SAMPLE SIZE CALCULATION The study sample size was calculated based on an individually randomized four arm design on the primary outcome of mean serum zinc levels and HbA1c. The mean HbA1c taken was 5.62% (SD 1.96) and mean zinc was 79.5 µg/dL (SD 35.9) according to NNS-2018. The serum zinc data for the Tharparkar district was taken from NNS 2018, while there is no data on area specific estimates for T2DM and HbA1c. A recent national community-based survey conducted in 2019 found that the prevalence of diabetes (19.09%) and pre-diabetes (12.79%) in rural areas of Pakistan is high compared to the urban areas of Pakistan (diabetes: 15.75%; prediabetes: 9.89%) and the overall mean HbA1c was 5.62% (SD 1.96).
The sample size was calculated with a power of 0.8 and alpha of 0.05 to detect a difference of at least 0.12 effect size in the mean serum zinc levels between groups and to detect a 0.2 effect size in the mean HbA1c levels with a dropout rate of 10%.
The sample size calculated is 250 participants. A total of 1000 participants would be randomly allocated to each of the groups in a 1:1:1:1 ratio.
Baseline, midline, and end-line data collection.
All the participants will be assessed at baseline, and at endline. Data will be collected on socio-demographic factors, dietary intake through 24-hour dietary recall, anthropometry (weight, height, MUAC, waist circumference), blood pressures and blood samples for bio-chemical analysis including serum zinc levels, FBS, HbA1C, insulin at both baseline and endline, while lipid profile and RBC membrane fatty acids would be done at endline only. At midline, 24-hour dietary recalls, serum zinc, and HbA1C will be taken on a subset from each group. For morbidity and ARI, a two-week data collection will be carried out.
- Conditions
- Malnutrition, Diabetes, Inflammation, Conjunctivitis
- Being tested
- Fermented High Zinc Wheat Flour Flatbread, Unfermented High Zinc Wheat Flour Flatbread, Post-Harvest Fortified Whole Wheat Flour Flatbread, Low Zinc Whole Wheat Flour Flatbread (Control Group)
- Keywords
- Zinc, Fortification, Micronutrient, Flour, Trial, Deficiencies
- Medical subject headings
- Malnutrition, Diabetes Mellitus, Inflammation, Conjunctivitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Fermented High Zinc Wheat Flour FlatbreadDietary supplement
- Participants in this group will receive flatbreads made from fermented high zinc wheat flour.
- The flatbreads will be prepared using traditional fermentation methods.
- These flatbreads will be provided to participants to consume daily, along with vegetables or pulses (daal), for six days a week over the course of six months.
Unfermented High Zinc Wheat Flour FlatbreadDietary supplement
- Participants in this group will receive flatbreads made from unfermented high zinc wheat flour,
- The flatbreads will not undergo a fermentation process.
- These flatbreads will be provided to participants to consume daily, along with vegetables or pulses (daal), for six days a week over the course of six months.
Post-Harvest Fortified Whole Wheat Flour FlatbreadDietary supplement
- Participants in this group will receive flatbreads made from whole wheat flour fortified post-harvest
- These fortified flatbreads will be provided to participants for daily consumption, along with vegetables or pulses (daal), for six days a week over the course of six months.
Low Zinc Whole Wheat Flour Flatbread (Control Group)Dietary supplement
- Participants in this group will serve as the control group.
- They will receive flatbreads made from whole wheat flour with a low zinc content
- These low zinc flatbreads will be provided to participants for daily consumption, along with vegetables or pulses (daal), for six days a week over the course of six months. six days a week over the course of six months.
| Study group | Role | What they receive |
|---|---|---|
| Fermented High Zinc Wheat Flour Flatbread | Experimental | Participants in this arm will receive fermented whole wheat flatbreads made from wheat variants with a high zinc content, ranging. These flatbreads are prepared through traditional fermentation methods. Receives: Dietary Supplement: Fermented High Zinc Wheat Flour Flatbread |
| Unfermented High Zinc Wheat Flour Flatbread | Experimental | Participants in this arm will receive unfermented whole wheat flatbreads made from wheat variants with a high zinc content. These flatbreads provide a source of bioavailable zinc without the fermentation process. Receives: Dietary Supplement: Unfermented High Zinc Wheat Flour Flatbread |
| Fortified Wheat Flour flatbread | Experimental | Participants in this arm will receive flatbreads made from whole wheat flour fortified post-harvest to contain a zinc content Receives: Dietary Supplement: Post-Harvest Fortified Whole Wheat Flour Flatbread |
| Low Zinc Wheat flatbread | Active comparator | Participants in this arm will receive whole wheat flatbreads made from wheat variants with a low zinc content Receives: Dietary Supplement: Low Zinc Whole Wheat Flour Flatbread (Control Group) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Zinc Status
The primary outcome is the measurement of serum zinc status (micrograms per deciliter (μg/dL) in participants. This includes assessing the concentration of zinc in serum samples. Changes in serum zinc levels will be compared between the four intervention groups.
Measured: Baseline and six months post intervention
Fasting Blood Glucose
This outcome assesses changes in participants' fasting blood glucose levels, measured in milligrams per deciliter (mg/dL). It aims to understand alterations in blood glucose levels resulting from flatbread interventions.
Measured: Baseline and six months post-intervention.
HbA1C Levels
This measure evaluates HbA1C levels, expressed as a percentage (%). It provides insights into long-term blood glucose control, helping assess the impact of dietary interventions.
Measured: Baseline and six months post-intervention.
Insulin Levels
This measure assesses participants' insulin levels, measured in microunits per milliliter (μU/mL). It helps in understanding changes in insulin sensitivity as a result of dietary interventions.
Measured: Baseline and six months post-intervention.
Lipid Profiles
This measure assesses participants' lipid profiles, with the unit of measure to be specified (e.g., milligrams per deciliter, mg/dL). It provides insights into changes in lipid levels and their potential effects on overall body composition due to dietary interventions.
Measured: Six months post-intervention.
Zinc Deficiency (%)
This primary outcome evaluates the prevalence of zinc deficiency among participants and it would be compared across the four groups.
Measured: Baseline and six months post intervention
Red blood cell membrane fatty acids concentrations
This outcome measures the red blood cell membrane fatty acids concentrations as a percentage (%) and This would be compared across the four groups.
Measured: At six months post intervention
Secondary outcomes (7)
Change in Weight (kg)
This outcome assesses changes in participants' weight, measured in kilograms (kg), to understand alterations in their physical characteristics resulting from flatbread interventions.
Measured: Six months post intervention
Change in Height (m)
This measure evaluates changes in participants' height, measured in meters (m), to determine any variations in their physical stature due to dietary changes.
Measured: Six months post intervention
Change in BMI (kg/m²)
Body Mass Index (BMI) is calculated using weight (in kilograms) and height (in meters) and is measured in kg/m². This measure provides insights into participants' overall body composition and potential effects of dietary changes.
Measured: Six months post intervention
Acceptability and Adherence Assessment
Secondary outcomes focus on participants' satisfaction and adherence to dietary interventions, offering insights into the feasibility and acceptability of the intervention.
Measured: Six months post intervention
School Attendance and Academic Performance
This outcome aims to determine if the intervention resulted in better school attendance and academic performance (determined by school) among participants.
Measured: Six months post intervention
Morbidity
This outcome monitors the incidence of common health infections as diarrhea and acute respiratory infections and will be reported as a percentage (%).
Measured: Six months post intervention
Anemia
Anemia will be assessed through hemoglobin levels and will be reported as a percentage (%). This will determine whether there was a difference among the four groups.
Measured: Six months post intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Oct 2023
- Study start1 Jan 2023
- Primary completion31 May 2024
- Study completion31 May 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for MalnutritionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This clinical trial investigates the health impact of consuming various types of wheat flour flatbreads among adolescent and adult females. The primary focus is on assessing zinc status and metabolic health in individuals at high risk of zinc deficiency and Type 2 Diabetes (T2DM). The study encompasses both fermented and unfermented flatbreads made from wheat variants with different zinc content and "post-harvest fortified wheat flour.
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 1,044 participants (actual)
Sponsor and investigators
- Lead sponsor
- Aga Khan University
- Sponsor type
- University, hospital or other
- Collaborators
- Bahauddin Zakariya University, University of California, The Hospital for Sick Children
- Responsible party
- Principal investigator, Dr Jai Kumar Das, Aga Khan University
- Investigators
- Jai K Das, Principal investigator, Aga Khan University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06092515
- Sponsor's protocol ID
- 2022-8164-23704
- Acronym
- EZAFFAW
- Status last verified
- Jun 2024
- First submitted
- 22 Sep 2023
- Last updated
- 4 Jun 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Das JK, Padhani ZA, Khan M, Mirani M, Rizvi A, Chauhadry IA, Yasin R, Ismail T, Akhtar S, Begum K, Iqbal J, Humayun K, Naseem HA, Malik KA, Bhutta ZA. Efficacy of Zinc Fortified and Fermented Wheat Flour (EZAFFAW): A randomized controlled trial protocol. PLoS One. 2024 Jun 20;19(6):e0304462. doi: 10.1371/journal.pone.0304462. eCollection 2024.
PubMed 38900773
Study at a glance
From the registry record, last updated by the sponsor on 4 Jun 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- EZAFFAW - Efficacy of Zinc Fortified Fermented Wheat Flour: Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06092515
- Acronym / sponsor ID
- EZAFFAW / 2022-8164-23704
- Conditions
- Malnutrition, Diabetes, Inflammation, Conjunctivitis
- Keywords
- Zinc, Fortification, Micronutrient, Flour, Trial, Deficiencies
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 1,044 participants (actual)
- Lead sponsor
- Aga Khan UniversityUniversity, hospital or other
- Collaborators
- Bahauddin Zakariya University, University of California, The Hospital for Sick Children
- Study start
- 1 Jan 2023 (actual)
- Primary completion
- 31 May 2024 (actual)
- Study completion
- 31 May 2024 (actual)
- First posted
- 23 Oct 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Zinc is a pivotal micronutrient that participates in numerous essential metabolic pathways within the human body. Its multifaceted role makes the manifestations of zinc deficiency remarkably nonspecific and age-dependent. In children, zinc deficiency can manifest as growth retardation, cognitive impairment, recurrent infections, and other diverse symptoms. Adolescents and adults may experience fertility issues, work capacity impairment, and metabolic disorders due to zinc deficiency. Furthermore, zinc plays a crucial role in maintaining immune function, particularly in the elderly, where recurrent infections can be a notable outcome of deficiency. Given its fundamental importance, the potential benefits of zinc supplementation and fortification strategies have been explored, with some evidence indicating positive effects on health outcomes such as childhood mortality, diarrhea morbidity, and even risk factors for conditions like Type 2 Diabetes (T2DM) and cardiovascular disease (CVD). Understanding zinc's significance in these metabolic processes is vital for addressing deficiencies and improving public health.
A study is needed to assess the effect of various types of fermented and unfermented wheat flour flatbread and its impact on health including zinc status, anthropometric outcomes, risk of T2DM and CVD and morbidity on adolescent and adult females. The whole wheat flatbread trial would be ideal to inform policy as it is regularly consumed in Sindh as most people rely on chakki for wheat grinding and it is used commonly to make roti at home.
Detailed description
STUDY DESIGN
This will be an individually randomized, double-blind efficacy trial in Mithi, District Tharparkar, Sindh, Pakistan. This district is among the most impoverished in Sindh, characterized by a tropical desert climate with extremely hot mornings. Approximately 87% of the population in Tharparkar lives below the poverty line. Due to its challenging demographics and environmental conditions, the region has endured severe droughts and faces the highest level of food insecurity among Sindh districts. It is concerning that 60% of children under five years suffer from stunting, 33.3% from wasting, and nearly 19.8% experience both conditions simultaneously. Additionally, approximately 40.4% of non-pregnant women of reproductive age are underweight. Tharparkar has been selected for this study due to its alarming rates of malnutrition and micronutrient deficiencies, making it an ideal location to assess the effectiveness of fortified wheat flour.
RESEARCH QUESTION
- Primary Does consumption of whole wheat flatbread made with fermented and unfermented 'high zinc wheat' or with 'post-harvest zinc-fortified wheat flour' improve zinc status and metabolic health among adolescents (10-19 years) and adult women (20-40 years) at high risk of zinc deficiency and T2DM compared to 'low zinc' whole wheat flatbread?
- Secondary Does an increase in bioavailable dietary zinc intake improve indicators for predicting the risk of T2DM in adolescents and adult women at high risk of zinc deficiency? SPECIFIC OBJECTIVES
- Primary To evaluate the efficacy of whole wheat flatbread made with fermented and unfermented 'high zinc wheat' or post-harvest zinc-fortified wheat on zinc status/zinc deficiency and metabolic health among adolescents and adult women at high risk of zinc deficiency when compared to the 'low zinc' whole wheat flatbread.
- Secondary To assess if an increase in bioavailable dietary zinc intake improves indicators for predicting the risk of T2DM in adolescents and adult women at high risk of zinc deficiency.
PARTICIPANTS The study will include adolescents (10-19 years) and adult women (20-40 years) INTERVENTION
Participants will be randomly divided into four groups according to the four-arm design in a 1:1:1:1 ratio. A total of 1000 participants would be randomly allocated to each of the groups in a 1:1:1:1 ratio.
- Group 1: will receive fermented high zinc wheat flour flatbread
- Group 2: will receive unfermented high zinc wheat flour flatbread
- Group 3: will receive fortified (post-harvest) whole wheat flour flatbread
- Group 4: will receive low zinc whole wheat flour flatbread
It would be a six-month intervention, where the participants would be given flatbread with a vegetable/pulse (daal) each day for six days a week for six months. On average, 2-3 flatbreads will be provided per participant (this was ascertained in the pilot activity). This would be provided at the school/college campus at lunch time i.e., at 1.30pm and all the participants enrolled in the study would be directly observed each day for the amount consumed and adult women would be provided meal at a community place.
OUTCOMES
Primary:
- Serum zinc concentration
- Zinc deficiency
- HbA1C
- Fasting blood glucose
- Insulin levels
- HOMA-IR (cut-off >2) (27)
- Lipid profile (total cholesterol, very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), high-density lipoprotein (HDL); triglycerides (TGs))
- Red blood cell membrane fatty acids concentrations
Secondary:
- Anthropometric measurements:
- Height
- Weight
- Mid upper arm circumference (MUAC)
- Waist circumference
- Body Mass Index (BMI) - Severe thinness, thinness, normal weight, overweight, obese
- Blood Pressure
- Anemia
- School attendance/ performance
- Dietary intakes through 24hr dietary recall.
- Morbidity - Diarrhea, Acute respiratory infection (ARI) etc.
Compliance:
- Number of days each participant had flatbread
- Flatbread consumed (weight) each day
SAMPLE SIZE CALCULATION The study sample size was calculated based on an individually randomized four arm design on the primary outcome of mean serum zinc levels and HbA1c. The mean HbA1c taken was 5.62% (SD 1.96) and mean zinc was 79.5 µg/dL (SD 35.9) according to NNS-2018. The serum zinc data for the Tharparkar district was taken from NNS 2018, while there is no data on area specific estimates for T2DM and HbA1c. A recent national community-based survey conducted in 2019 found that the prevalence of diabetes (19.09%) and pre-diabetes (12.79%) in rural areas of Pakistan is high compared to the urban areas of Pakistan (diabetes: 15.75%; prediabetes: 9.89%) and the overall mean HbA1c was 5.62% (SD 1.96).
The sample size was calculated with a power of 0.8 and alpha of 0.05 to detect a difference of at least 0.12 effect size in the mean serum zinc levels between groups and to detect a 0.2 effect size in the mean HbA1c levels with a dropout rate of 10%.
The sample size calculated is 250 participants. A total of 1000 participants would be randomly allocated to each of the groups in a 1:1:1:1 ratio.
Baseline, midline, and end-line data collection.
All the participants will be assessed at baseline, and at endline. Data will be collected on socio-demographic factors, dietary intake through 24-hour dietary recall, anthropometry (weight, height, MUAC, waist circumference), blood pressures and blood samples for bio-chemical analysis including serum zinc levels, FBS, HbA1C, insulin at both baseline and endline, while lipid profile and RBC membrane fatty acids would be done at endline only. At midline, 24-hour dietary recalls, serum zinc, and HbA1C will be taken on a subset from each group. For morbidity and ARI, a two-week data collection will be carried out.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 4
- Model description
- This clinical trial investigates the health impact of consuming various types of wheat flour flatbreads among adolescent and adult females. The primary focus is on assessing zinc status and metabolic health in individuals at high risk of zinc deficiency and Type 2 Diabetes (T2DM). The study encompasses both fermented and unfermented flatbreads made from wheat variants with different zinc content and "post-harvest fortified wheat flour.
| Arm | Type | Receives |
|---|---|---|
| Fermented High Zinc Wheat Flour Flatbread | Experimental | Dietary Supplement: Fermented High Zinc Wheat Flour FlatbreadParticipants in this arm will receive fermented whole wheat flatbreads made from wheat variants with a high zinc content, ranging. These flatbreads are prepared through traditional fermentation methods. |
| Unfermented High Zinc Wheat Flour Flatbread | Experimental | Dietary Supplement: Unfermented High Zinc Wheat Flour FlatbreadParticipants in this arm will receive unfermented whole wheat flatbreads made from wheat variants with a high zinc content. These flatbreads provide a source of bioavailable zinc without the fermentation process. |
| Fortified Wheat Flour flatbread | Experimental | Dietary Supplement: Post-Harvest Fortified Whole Wheat Flour FlatbreadParticipants in this arm will receive flatbreads made from whole wheat flour fortified post-harvest to contain a zinc content |
| Low Zinc Wheat flatbread | Active comparator | Dietary Supplement: Low Zinc Whole Wheat Flour Flatbread (Control Group)Participants in this arm will receive whole wheat flatbreads made from wheat variants with a low zinc content |
Who may qualify
- Ages
- 10 to 40 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (3 listed)
- Adolescents aged 10-19 years
- Adult women aged 20-40 years.
- Wheat as a staple part of their diet
Key exclusion criteria (6 listed)
- Severe Malnutrition
- Pregnant or Lactating
- Chronic Diseases
- Participation in Similar Programs
- Individuals taking vitamin or mineral supplements at the time of enrollment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Fermented High Zinc Wheat Flour Flatbread* Participants in this group will receive flatbreads made from fermented high zinc wheat flour. * The flatbreads will be prepared using traditional fermentation methods. * These flatbreads will be provided to participants to consume daily, along with vegetables or pulses (daal), for six days a week over the course of six months. | Dietary supplement | Fermented High Zinc Wheat Flour Flatbread |
| Unfermented High Zinc Wheat Flour Flatbread* Participants in this group will receive flatbreads made from unfermented high zinc wheat flour, * The flatbreads will not undergo a fermentation process. * These flatbreads will be provided to participants to consume daily, along with vegetables or pulses (daal), for six days a week over the course of six months. | Dietary supplement | Unfermented High Zinc Wheat Flour Flatbread |
| Post-Harvest Fortified Whole Wheat Flour Flatbread* Participants in this group will receive flatbreads made from whole wheat flour fortified post-harvest * These fortified flatbreads will be provided to participants for daily consumption, along with vegetables or pulses (daal), for six days a week over the course of six months. | Dietary supplement | Fortified Wheat Flour flatbread |
| Low Zinc Whole Wheat Flour Flatbread (Control Group)* Participants in this group will serve as the control group. * They will receive flatbreads made from whole wheat flour with a low zinc content * These low zinc flatbreads will be provided to participants for daily consumption, along with vegetables or pulses (daal), for six days a week over the course of six months. six days a week over the course of six months. | Dietary supplement | Low Zinc Wheat flatbread |
Primary outcome
Zinc Status
Time frame: Baseline and six months post intervention
The primary outcome is the measurement of serum zinc status (micrograms per deciliter (μg/dL) in participants. This includes assessing the concentration of zinc in serum samples. Changes in serum zinc levels will be compared between the four intervention groups.
Fasting Blood Glucose
Time frame: Baseline and six months post-intervention.
This outcome assesses changes in participants' fasting blood glucose levels, measured in milligrams per deciliter (mg/dL). It aims to understand alterations in blood glucose levels resulting from flatbread interventions.
HbA1C Levels
Time frame: Baseline and six months post-intervention.
This measure evaluates HbA1C levels, expressed as a percentage (%). It provides insights into long-term blood glucose control, helping assess the impact of dietary interventions.
Insulin Levels
Time frame: Baseline and six months post-intervention.
This measure assesses participants' insulin levels, measured in microunits per milliliter (μU/mL). It helps in understanding changes in insulin sensitivity as a result of dietary interventions.
Lipid Profiles
Time frame: Six months post-intervention.
This measure assesses participants' lipid profiles, with the unit of measure to be specified (e.g., milligrams per deciliter, mg/dL). It provides insights into changes in lipid levels and their potential effects on overall body composition due to dietary interventions.
Zinc Deficiency (%)
Time frame: Baseline and six months post intervention
This primary outcome evaluates the prevalence of zinc deficiency among participants and it would be compared across the four groups.
Red blood cell membrane fatty acids concentrations
Time frame: At six months post intervention
This outcome measures the red blood cell membrane fatty acids concentrations as a percentage (%) and This would be compared across the four groups.
7 secondary outcomes
Change in Weight (kg)
Time frame: Six months post intervention
Change in Height (m)
Time frame: Six months post intervention
Change in BMI (kg/m²)
Time frame: Six months post intervention
Acceptability and Adherence Assessment
Time frame: Six months post intervention
School Attendance and Academic Performance
Time frame: Six months post intervention
Morbidity
Time frame: Six months post intervention
Anemia
Time frame: Six months post intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Jun 2024.
- Derived from this study: PubMed 38900773Das JK, Padhani ZA, Khan M, Mirani M, Rizvi A, Chauhadry IA, Yasin R, Ismail T, Akhtar S, Begum K, Iqbal J, Humayun K, Naseem HA, Malik KA, Bhutta ZA. Efficacy of Zinc Fortified and Fermented Wheat Flour (EZAFFAW): A randomized controlled trial protocol. PLoS One. 2024 Jun 20;19(6):e0304462. doi: 10.1371/journal.pone.0304462. eCollection 2024.
Related trials for Malnutrition
RecruitingPhase 1/2
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
X-linked Hypophosphatemia
Recruiting
Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)
Diabetes Mellitus, Type 2, Nutrition Poor
Active, not recruiting
Evaluation of Personalized Nutritional Intervention on Wound Healing of Cutaneous Ulcers in Diabetics
Foot, Diabetic
Active, not recruitingPhase 2
Maternal Probiotic Intervention to Improve Gut Health-Trial II-Pakistan
Environmental Enteric Dysfunction (EED), Stunting
Not yet recruitingObservational study
Biomarkers in EV Associated With Marrow Adiposity in Anorexia
Anorexia Nervosa Restricting Type, Anorexia Nervosa (DSM-IV Revised Criteria)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jai K Das principal investigator
Aga Khan University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Fermented High Zinc Wheat Flour Flatbread, Unfermented High Zinc Wheat Flour Flatbread and Post-Harvest Fortified Whole Wheat Flour Flatbread in people with Malnutrition and Diabetes, run by Aga Khan University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Zinc Status (time frame: Baseline and six months post intervention). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06092515, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2024.